AtriCure market cap is $1.2 b, and annual revenue was $201.63 m in FY 2018

AtriCure Gross profit (Q2, 2019)43.9 M

AtriCure Gross profit margin (Q2, 2019), %74.5%

AtriCure Net income (Q2, 2019)-4.1 M

AtriCure EBIT (Q2, 2019)-3.8 M

AtriCure Cash, 30-Jun-201925.2 M

AtriCure EV1.2 B

AtriCure revenue was $201.63 m in FY, 2018

USD | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 | FY, 2017 | FY, 2018 |
---|---|---|---|---|---|---|

## Revenue | 81.9m | 107.5m | 129.8m | 155.1m | 174.7m | 201.6m |

| 31% | 21% | 20% | |||

## Cost of goods sold | 22.3m | 31.7m | 36.9m | 44.0m | 48.6m | 54.5m |

## Gross profit | 59.6m | 75.8m | 92.9m | 111.1m | 126.2m | 147.1m |

| 73% | 70% | 72% | 72% | 72% | 73% |

## R&D expense | 25.7m | 35.8m | 34.1m | 34.7m | ||

## General and administrative expense | 93.9m | 106.4m | 117.0m | 129.5m | ||

## Operating expense total | 119.6m | 142.2m | 151.1m | 164.2m | ||

## EBIT | 10.9m | (16.4m) | (26.7m) | (31.1m) | (25.0m) | (17.1m) |

| 13% | (15%) | (21%) | (20%) | (14%) | (8%) |

## Interest expense | 566.0k | 305.0k | 292.0k | 1.8m | 2.3m | 4.6m |

## Interest income | 16.0k | 96.0k | 190.0k | 227.0k | 227.0k | 1.0m |

## Pre tax profit | (27.2m) | (33.3m) | (26.9m) | (20.9m) | ||

## Income tax expense | 18.0k | (33.0k) | (36.0k) | 40.0k | 14.0k | 226.0k |

## Net Income | (11.5m) | (16.2m) | (27.2m) | (33.3m) | (26.9m) | (21.1m) |

USD | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 | FY, 2017 | FY, 2018 |
---|---|---|---|---|---|---|

## Cash | 14.9m | 28.4m | 23.8m | 24.2m | 21.8m | 32.2m |

## Accounts Receivable | ||||||

## Inventories | 10.2m | 14.3m | 17.7m | 17.7m | 22.5m | 22.5m |

## Current Assets | 52.5m | 93.5m | 74.8m | 85.7m | 82.3m | 174.7m |

## PP&E | 5.6m | 11.6m | 31.3m | 30.0m | 28.7m | 27.1m |

## Goodwill | 35.4m | 35.4m | 105.3m | 105.3m | 105.3m | 105.3m |

## Total Assets | 111.9m | 158.4m | 273.1m | 276.4m | 267.7m | 356.8m |

## Accounts Payable | 8.6m | 7.6m | 12.7m | 10.7m | 12.4m | 9.7m |

## Short-term debt | ||||||

## Current Liabilities | 26.7m | 25.6m | 31.6m | 28.8m | 31.9m | 40.2m |

## Long-term debt | 23.9m | 24.1m | 35.6m | |||

## Total Debt | 23.9m | 24.1m | 35.6m | |||

## Total Liabilities | 86.4m | 108.0m | 106.5m | 107.4m | ||

## Additional Paid-in Capital | 194.9m | 271.3m | 352.9m | 367.9m | 387.0m | 496.5m |

## Retained Earnings | (122.2m) | (138.4m) | (165.6m) | (199.0m) | (225.9m) | (247.0m) |

## Total Equity | 72.6m | 132.5m | 186.7m | 168.4m | 161.2m | 249.4m |

## Debt to Equity Ratio | 0.1 x | 0.1 x | ||||

## Debt to Assets Ratio | 0.1 x | 0.1 x | ||||

## Financial Leverage | 1.5 x | 1.2 x | 1.5 x | 1.6 x | 1.7 x | 1.4 x |

USD | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 | FY, 2017 | FY, 2018 |
---|---|---|---|---|---|---|

## Net Income | (11.5m) | (16.2m) | (27.2m) | (33.3m) | (26.9m) | (21.1m) |

## Depreciation and Amortization | 2.0m | 4.8m | 6.3m | 9.3m | 9.1m | 8.8m |

## Accounts Receivable | (1.2m) | (4.2m) | (900.0k) | (2.0m) | (1.5m) | (2.8m) |

## Inventories | (2.3m) | (4.3m) | (2.9m) | (79.0k) | (4.5m) | (146.0k) |

## Accounts Payable | 1.4m | (944.0k) | 4.0m | (1.1m) | 1.3m | (2.4m) |

## Cash From Operating Activities | (5.2m) | (21.6m) | (7.8m) | (15.1m) | (8.9m) | (4.2m) |

## Purchases of PP&E | (9.2m) | (13.4m) | (7.7m) | (6.4m) | (6.2m) | |

## Cash From Investing Activities | (14.2m) | (30.6m) | (10.5m) | (12.1m) | 3.8m | (85.4m) |

## Cash From Financing Activities | 26.8m | 65.9m | 14.0m | 27.7m | 2.8m | 100.2m |

## Interest Paid | 473.0k | 115.0k | 232.0k | 1.5m | 2.0m | 3.9m |

## Income Taxes Paid | 30.0k | 146.0k | 20.0k | 30.0k | 37.0k | 65.0k |

USD | Y, 2019 |
---|---|

## EV/EBIT | -267 x |

## EV/CFO | -105.8 x |

## Financial Leverage | 1.4 x |